You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 385 Selection of CD8+CD103+CD31- tumor infiltrating lymphocytes (TIL) from bulk cultures enriches tumor-specific reactivity in a patient-agnostic manner

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Cellular Therapies
385 Selection of CD8+CD103+CD31- tumor infiltrating lymphocytes (TIL) from bulk cultures enriches tumor-specific reactivity in a patient-agnostic manner

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023194018
Dec 20235707
Jan 20243402
Feb 20242202
Mar 20244404
Apr 20242802
May 20241601
Jun 20241200
Jul 20243000
Aug 20242002
Sep 20245402
Oct 20242009
Nov 20243603
Dec 20243405
Jan 20255008
Feb 2025206
Mar 2025007
Apr 2025001
May 20250011
Jun 2025003
Total653093